178 Tumor neoantigen prioritization from liquid biopsy whole exome sequencing for selected tumor-infiltrating lymphocyte therapy

Samankaltaisia teoksia

• 900 TBio BFX 4101: a neoantigen prioritization pipeline for selected tumor-infiltrating lymphocyte therapy
  Tekijä: Quanyuan He, et al.
  Julkaistu: (2023-11-01)
• 346 Expansion and identification of neoantigen reactive tumor infiltrating lymphocytes (TIL) from metastatic colorectal (CRC) and GI cancers
  Tekijä: Amy Hall, et al.
  Julkaistu: (2023-11-01)
• Tumor neoantigens and tumor immunotherapies
  Tekijä: Wang Jiani, et al.
  Julkaistu: (2024-04-01)
• Screening tumor stage-specific candidate neoantigens in thyroid adenocarcinoma using integrated exome and transcriptome sequencing
  Tekijä: Meng Jia, et al.
  Julkaistu: (2023-10-01)
• The interplay between cancer type, panel size and tumor mutational burden threshold in patient selection for cancer immunotherapy.
  Tekijä: Mahdi Golkaram, et al.
  Julkaistu: (2020-11-01)